BACKGROUND/AIMS: We identified and studied 13 patients carrying the P301L mutation in the MAPT gene from the same area (Baix Llobregat County) in Barcelona, Spain. METHODS: The demographic and clinical features were reviewed retrospectively. Detailed neuropathological characterization was obtained in 9 subjects. To investigate the origin of the P301L mutation in these families, 20 single nucleotide polymorphisms (SNPs) in the MAPT gene were analyzed. RESULTS: The mean age at disease onset was 51 years and the mean disease duration was 7 years. The most common initial symptoms were behavioral changes (54%), followed by language disturbances (31%) and memory loss (15%). 46% developed parkinsonism. Neuropathology showed an extensive neuronal and glial 4-repeat (4R) tauopathy with "mini-Pick"-like bodies in the dentate gyrus as the characteristic underlying pathology in all cases. In 1 subject, additional 4R globular glial inclusions were observed. All the mutation carriers showed the same haplotype for the SNPs analyzed, suggesting a common ancestor. CONCLUSION: These findings suggest a relative homogeneous clinicopathological phenotype in P301L MAPT mutation carriers in our series. This phenotype might help in the differential diagnosis from other tauopathies and be a morphological hint for genetic testing. The haplotype analysis results suggest a founder effect of the P301L mutation in this area.
BACKGROUND/AIMS: We identified and studied 13 patients carrying the P301L mutation in the MAPT gene from the same area (Baix Llobregat County) in Barcelona, Spain. METHODS: The demographic and clinical features were reviewed retrospectively. Detailed neuropathological characterization was obtained in 9 subjects. To investigate the origin of the P301L mutation in these families, 20 single nucleotide polymorphisms (SNPs) in the MAPT gene were analyzed. RESULTS: The mean age at disease onset was 51 years and the mean disease duration was 7 years. The most common initial symptoms were behavioral changes (54%), followed by language disturbances (31%) and memory loss (15%). 46% developed parkinsonism. Neuropathology showed an extensive neuronal and glial 4-repeat (4R) tauopathy with "mini-Pick"-like bodies in the dentate gyrus as the characteristic underlying pathology in all cases. In 1 subject, additional 4R globular glial inclusions were observed. All the mutation carriers showed the same haplotype for the SNPs analyzed, suggesting a common ancestor. CONCLUSION: These findings suggest a relative homogeneous clinicopathological phenotype in P301LMAPT mutation carriers in our series. This phenotype might help in the differential diagnosis from other tauopathies and be a morphological hint for genetic testing. The haplotype analysis results suggest a founder effect of the P301L mutation in this area.
Authors: M E Erro; M V Zelaya; M Mendioroz; R Larumbe; S Ortega-Cubero; J L Lanciego; A Lladó; T Cabada; T Tuñón; F García-Bragado; M R Luquin; P Pastor; I Ferrer Journal: J Neurol Date: 2019-06-12 Impact factor: 4.849
Authors: Harro Seelaar; David J Irwin; Lucia A A Giannini; Daniel T Ohm; Annemieke J M Rozemuller; Laynie Dratch; EunRan Suh; Vivianna M van Deerlin; John Q Trojanowski; Edward B Lee; John C van Swieten; Murray Grossman Journal: Acta Neuropathol Date: 2022-09-06 Impact factor: 15.887
Authors: Isidro Ferrer; Meritxell Aguiló García; Margarita Carmona; Pol Andrés-Benito; Benjamin Torrejón-Escribano; Paula Garcia-Esparcia; José Antonio Del Rio Journal: Front Aging Neurosci Date: 2019-05-28 Impact factor: 5.750
Authors: Sergi Borrego-Écija; Anna Antonell; Joan Anton Puig-Butillé; Inmaculada Pericot; Carme Prat-Bravo; Maria Teresa Abellan-Vidal; Javier Mallada; Jaume Olives; Neus Falgàs; Rafael Oliva; Albert Lladó; Raquel Sánchez-Valle Journal: Ann Clin Transl Neurol Date: 2019-07-17 Impact factor: 4.511
Authors: Mica T M Clarke; Frédéric St-Onge; Jonathan D Rohrer; Robert Laforce; Jean-Mathieu Beauregard; Martina Bocchetta; Emily Todd; David M Cash Journal: Alzheimers Res Ther Date: 2021-02-10 Impact factor: 6.982
Authors: Isidro Ferrer; Pol Andrés-Benito; Maria Victoria Zelaya; Maria Elena Erro Aguirre; Margarita Carmona; Karina Ausín; Mercedes Lachén-Montes; Joaquín Fernández-Irigoyen; Enrique Santamaría; José Antonio Del Rio Journal: Acta Neuropathol Date: 2020-01-06 Impact factor: 17.088